The Patent Finder

Genomas, Inc.

Also on record
Records under this name other than patents Genomas, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Genomas, Inc.

PatentTitleStatus Expires Confidence
US 9,558,320Physiogenomic method for predicting drug metabolism reserve for antidepressants and stimulants
Lapsed on the fee record
Ended Jan 31, 2021 · From the USPTO record
Lapsed on the fee recordEnded Jan 31, 2021From the USPTO record
US 8,012,718Physiogenomic method for predicting diabetes and metabolic syndromes induced by psychotropic drugs
Lapsed on the fee record
Ended Sep 6, 2019 · From the USPTO record
Lapsed on the fee recordEnded Sep 6, 2019From the USPTO record
US 7,747,392Physiogenomic method for predicting clinical outcomes of treatments in patients
Lapsed on the fee record
Ended Jun 29, 2018 · From the USPTO record
Lapsed on the fee recordEnded Jun 29, 2018From the USPTO record
US 8,476,012Physiogenomic method for predicting metabolic and cardiovascular side effects of thiazolidinediones
Lapsed on the fee record
Ended Jul 2, 2017 · From the USPTO record
Lapsed on the fee recordEnded Jul 2, 2017From the USPTO record
US 8,389,247Physiogenomic method for predicting diabetes and metabolic syndromes induced by psychotropic drugs
Lapsed on the fee record
Ended Mar 5, 2017 · From the USPTO record
Lapsed on the fee recordEnded Mar 5, 2017From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited